These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15724939)

  • 1. [Low-molecular heparins in the treatment of non-ST elevation acute coronary syndrome].
    Komarov AL; Panchenko EP
    Ter Arkh; 2004; 76(12):93-6. PubMed ID: 15724939
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
    Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerning to low molecular weight heparins (LMWHs) in acut coronary syndromes.
    Borja J; Olivella P
    S D J Med; 2000 Jul; 53(7):277-9. PubMed ID: 10932610
    [No Abstract]   [Full Text] [Related]  

  • 4. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-molecular-weight heparins in acute coronary syndrome: acquired results and new perspectives].
    Ugo F; Ardissino D
    G Ital Cardiol (Rome); 2006 Dec; 7(12):771-9. PubMed ID: 17294602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events.
    Zhang LJ; Chen YD; Song XT; Zhao FH; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(5):502-8. PubMed ID: 19323898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.
    Collet JP; Montalescot G; Agnelli G; Van de Werf F; Gurfinkel EP; López-Sendón J; Laufenberg CV; Klutman M; Gowda N; Gulba D;
    Eur Heart J; 2005 Nov; 26(21):2285-93. PubMed ID: 15932908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparins in cardiovascular medicine.
    De Lorenzo F; Dotsenko O; Kakkar VV
    Minerva Cardioangiol; 2005 Dec; 53(6):585-603. PubMed ID: 16333240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical predictors of left main coronary artery disease in high-risk patients with a first episode of non-ST-segment elevation acute coronary syndrome].
    Claver E; Curós A; López-Ayerbe J; Serra J; Mauri J; Fernández-Nofrerias E; Rodríguez-Leor O; Bernal E; Valle V
    Rev Esp Cardiol; 2006 Aug; 59(8):794-800. PubMed ID: 16938228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively.
    Dziewierz A; Siudak Z; Rakowski T; Mielecki W; Giszterowicz D; Dubiel JS; Dudek D
    Coron Artery Dis; 2007 Jun; 18(4):299-303. PubMed ID: 17496494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome.
    Mälarstig A; Wallentin L; Siegbahn A
    Thromb Res; 2007; 119(4):467-73. PubMed ID: 16782174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
    Han JH; Chandra A; Mulgund J; Roe MT; Peterson ED; Szczech LA; Patel U; Ohman EM; Lindsell CJ; Gibler WB
    Am J Med; 2006 Mar; 119(3):248-54. PubMed ID: 16490471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes.
    Yan AT; Yan RT; Tan M; Fung A; Cohen EA; Fitchett DH; Langer A; Goodman SG;
    Arch Intern Med; 2007 May; 167(10):1009-16. PubMed ID: 17533203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalteparin as the primary low-molecular-weight heparin on a hospital formulary.
    Goldman MC
    Conn Med; 2009 Jan; 73(1):23-8. PubMed ID: 19248570
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of heparins in Non-ST-elevation acute coronary syndromes.
    Gore JM; Spencer FA; Goldberg RJ; Kennelly BM; Fox KA; Allegrone J; Eagle KA; Anderson FA; Steg PG;
    Am J Med; 2007 Jan; 120(1):63-71. PubMed ID: 17208081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute ST-segment elevation also possible in non-coronary disorders].
    Jessurun GA; Zijlstra F; Siebelink HJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):937-42. PubMed ID: 17225732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
    Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of low-molecular-weight heparins in the management of unstable angina and non-ST elevation myocardial infarction.
    Alwi I
    Acta Med Indones; 2008 Oct; 40(4):228-32. PubMed ID: 19530369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U; Gitt A; Jünger C; Koeth O; Zahn R; Wienbergen H; Gottwik M; Senges J;
    Am J Cardiol; 2006 Jul; 98(1):19-22. PubMed ID: 16784913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.